BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27460080)

  • 1. Systemic transcriptome analysis of hepatocellular carcinoma.
    Yu CB; Zhu LY; Wang YG; Li F; Zhang XY; Dai WJ
    Tumour Biol; 2016 Oct; 37(10):13323-13331. PubMed ID: 27460080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
    Li J; Chen N; Gong X
    Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
    Li G; Xu W; Zhang L; Liu T; Jin G; Song J; Wu J; Wang Y; Chen W; Zhang C; Chen X; Ding Z; Zhu P; Zhang B
    EBioMedicine; 2019 Sep; 47():128-141. PubMed ID: 31492561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
    Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
    Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five Core Genes Related to the Progression and Prognosis of Hepatocellular Carcinoma Identified by Analysis of a Coexpression Network.
    Kong J; Wang T; Zhang Z; Yang X; Shen S; Wang W
    DNA Cell Biol; 2019 Dec; 38(12):1564-1576. PubMed ID: 31633379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
    Hu B; Yang XB; Sang XT
    Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of DNA methylation and gene expression reveals distinct hepatocellular carcinoma subtypes with therapeutic implications.
    Huang X; Yang C; Wang J; Sun T; Xiong H
    Aging (Albany NY); 2020 Mar; 12(6):4970-4995. PubMed ID: 32201399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis.
    Benfeitas R; Bidkhori G; Mukhopadhyay B; Klevstig M; Arif M; Zhang C; Lee S; Cinar R; Nielsen J; Uhlen M; Boren J; Kunos G; Mardinoglu A
    EBioMedicine; 2019 Feb; 40():471-487. PubMed ID: 30606699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
    Liao LE; Hu DD; Zheng Y
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
    Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
    Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
    He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
    BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The underlying pathophysiology association between the Type 2-diabetic and hepatocellular carcinoma.
    Wei H; Wang J; Li W; Ma R; Xu Z; Luo Z; Lu Y; Zhang X; Long X; Pu J; Tang Q
    J Cell Physiol; 2019 Jul; 234(7):10835-10841. PubMed ID: 30585632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
    Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
    Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
    Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
    Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.